Stimulation of allergen-loaded macrophages by TLR9-ligand potentiates IL-10-mediated suppression of allergic airway inflammation in mice

Respiratory Research

Volumn 5, Issue , 2004, Pages

  Vissers, Joost L M ^a   van Esch, Betty C A M ^a   Jeurink, Prescilla V ^a   Hofman, Gerard A ^a   van Oosterhout, Antoon J M ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; INTERLEUKIN 10; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; OLIGODEOXYNUCLEOTIDE; OVALBUMIN; TOLL LIKE RECEPTOR 9; OLIGODEOXYRIBONUCLEOTIDE; TLR4 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 4;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG POTENTIATION; EOSINOPHILIA; EX VIVO STUDY; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; IN VITRO STUDY; LUNG LAVAGE; MACROPHAGE; MALE; MOUSE; NONHUMAN; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; IMMUNOLOGY; MACROPHAGE ACTIVATION; MOUSE MUTANT; RESPIRATORY TRACT ALLERGY;

ANIMALS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; OLIGODEOXYRIBONUCLEOTIDES; OVALBUMIN; RESPIRATORY HYPERSENSITIVITY; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9;

EID: 17244365364     PISSN: 1465993X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1465-9921-5-21     Document Type: Article

References (49)

1. Romagnani S: Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 1992, 98:279-285.
2. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB: Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992, 326:298-304.
3. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
4. Hilkens CM, Kalinski P, de Boer M, Kapsenberg ML: Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood 1997, 90:1920-1926.
5. Akbari O, DeKruyff RH, Umetsu DT: Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001, 2:725-731.
6. Weiner HL: The mucosal milieu creates tolerogenic dendritic cells and TR1 and TH3 regulatory cells. Nat Immunol 2001, 2:671-672.
7. Goerdt S, Orfanos CE: Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999, 10:137-142.
8. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35.
9. Laskin DL, Weinberger B, Laskin JD: Functional heterogeneity in liver and lung macrophages. J Leukoc Biol 2001, 70:163-170.
10. Sibille Y, Reynolds HY: Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990, 141:471-501.
11. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM: Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993, 260:547-549.
12. Desmedt M, Rottiers P, Dooms H, Fiers W, Grooten J: Macrophages induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses. J Immunol 1998, 160:5300-5308.
13. Brewer JM, Richmond J, Alexander J: The demonstration of an essential role for macrophages in the in vivo generation of IgG2a antibodies. Clin Exp Immunol 1994, 97:164-171.
14. Tang C, Inman MD, van Rooijen N, Yang P, Shen H, Matsumoto K, O'Byrne PM: Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism. J Immunol 2001, 166:1471-1481.
15. Peterson JD, Herzenberg LA, Vasquez K, Waltenbaugh C: Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci U S A 1998, 95:3071-3076.
16. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM: M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000, 164:6166-6173.
17. Grbic JT, Mannick JA, Gough DB, Rodrick ML: The role of prostaglandin E2 in immune suppression following injury. Ann Surg 1991, 214:253-263.
18. Thepen T, Kraal G, Holt PG: The role of alveolar macrophages in regulation of lung inflammation. Ann N Y Acad Sci 1994, 725:200-206.
19. Strickland DH, Thepen T, Kees UR, Kraal G, Holt PG: Regulation of T-cell function in lung tissue by pulmonary alveolar macrophages. Immunology 1993, 80:266-272.
20. Upham JW, Strickland DH, Bilyk N, Robinson BW, Holt PG: Alveolar macrophages from humans and rodents selectively inhibit T-cell proliferation but permit T-cell activation and cytokine secretion. Immunology 1995, 84:142-147.
21. Holt PG, Oliver J, Bilyk N, McMenamin C, McMenamin PG, Kraal G, Thepen T: Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med 1993, 177:397-407.
22. Holt PG, Batty JE, Turner KJ: Inhibition of specific IgE responses in mice by pre-exposure to inhaled antigen. Immunology 1981, 42:409-417.
23. McMenamin C, Holt PG: The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. J Exp Med 1993, 178:889-899.
24. Seymour BW, Gershwin LJ, Coffman RL: Aerosol-induced immunoglobulin (Ig)-E unresponsiveness to ovalbumin does not require CD8+ or T cell receptor (TCR)-gamma/delta+ T cells or interferon (IFN)-gamma in a murine model of allergen sensitization. J Exp Med 1998, 187:721-731.
25. Thepen T, McMenamin C, Girn B, Kraal G, Holt PG: Regulation of IgE production in pre-sensitized animals: in vivo elimination of alveolar macrophages preferentially increases IgE responses to inhaled allergen. Clin Exp Allergy 1992, 22:1107-1114.
26. Janssen EM, Wauben MHM, Nijkamp FP, van Eden W, Van Oosterhout AJM: Immunomodulatory effects of antigen-pulsed macrophages in a murine model of allergic asthma. Am J Respir Cell Mol Biol 2002, 27:257-264.
27. Pynaert G, Rottiers P, Haegeman A, Sehra S, Van-Belle T, Korf J, Grooten J: Antigen presentation by local macrophages promotes nonallergic airway responses in sensitized mice. Am J Respir Cell Mol Biol 2003, 29:634-41.
28. Medzhitov R: Toll-like receptors and innate immunity. Nature Rev Immunol 2001, 1:135-145.
29. Wagner H: Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity. Curr Opin Microbiol 2002, 5:62-69.
30. Nicklas W, Baneux P, Boot R, Decelle T, Deeny AA, Fumanelli M, Illgen-Wilcke B: Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab Anim 2002, 36:20-42.
31. Roman M, Martin-Orozco E, Goodman JS, Nguyen MD, Sato Y, Ronaghy A, Kornbluth RS, Richman DD, Carson DA, Raz E: Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 1997, 3:849-854.
32. Hessel EM, Van Oosterhout AJM, Hofstra CL, de Bie JJ, Garssen J, Van Loveren H, Verheyen AK, Savelkoul HF, Nijkamp FP: Bronchoconstriction and airway hyperresponsiveness after ovalbumin inhalation in sensitized mice. Eur J Pharmacol 1995, 293:401-412.
33. Van Oosterhout AJM, Van Esch B, Hofman G, Hofstra CL, Van AI, Nijkamp FP, Kapsenberg ML, Savelkoul HF, Weller FR: Allergen immunotherapy inhibits airway eosinophilia and hyperresponsiveness associated with decreased IL-4 production by lymphocytes in a murine model of allergic asthma. Am J Respir Cell Mol Biol 1998, 19:622-628.
34. Yi AK, Yoon JG, Yeo SJ, Hong SC, English BK, Krieg AM: Role of mitogen-activated protein kinases in CpG DNA-mediated IL-10 and IL-12 production: central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 response. J Immunol 2002, 168:4711-4720.
35. Bates J, Irvin C, Brusasco V, Drazen J, Fredberg J, Loring S, Eidelman D, Ludwig M, Macklem P, Martin J, Milic-Emili J, Hantos Z, Hyatt R, Lai-Fook S, Leff A, Solway J, Lutchen K, Suki B, Mitzner W, Pare P, Pride N, Sly P: The use and misuse of Penh in animal models of lung disease. Am J Respir Cell Mol Biol 2004, 31:373-374.
36. Ahmad-Nejad P, Hacker H, Rutz M, Bauer S, Vabulas RM, Wagner H: Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur J Immunol 2002, 32:1958-1968.
37. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991, 174:1209-1220.
38. Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM: IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993, 51:1224-1234.
39. Van Ommen R, Vredendaal AE, Savelkoul HF: Secondary IgE responses in vivo are predominantly generated via gamma 1 epsilon-double positive B cells. Scand J Immunol 1994, 40:491-501.
40. Gordon S, Fraser I, Nath D, Hughes D, Clarke S: Macrophages in tissues and in vitro. Curr Opin Immunol 1992, 4:25-32.
41. Stampfli MR, Cwiartka M, Gajewska BU, Alvarez D, Ritz SA, Inman MD, Xing Z, Jordana M: Interleukin-10 gene transfer to the airway regulates allergic mucosal sensitization in mice. Am J Respir Cell Mol Biol 1999, 21:586-596.
42. Adachi M, Oda N, Kokubu F, Minoguchi K: IL-10 induces a Th2 cell tolerance in allergic asthma. Int Arch Allergy Immunol 1999, 118:391-394.
43. Oh JW, Seroogy CM, Meyer EH, Akbari O, Berry G, Fathman CG, Dekruyff RH, Umetsu DT: CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation. J Allergy Clin Immunol 2002, 110:460-468.
44. Salez L, Singer M, Balloy V, Creminon C, Chignard M: Lack of IL-10 synthesis by murine alveolar macrophages upon lipoposaccharide exposure: Comparison with peritoneal macrophages. J Leukoc Biol 2000, 67:545-552.
45. Gosset P, Tillie-Leblond I, Oudin S, Parmentier O, Wallaert B, Joseph M, Tonnel AB: Production of chemokines and proinflammatory and antiinflammatory cytokines by human alveolar macrophages activated by IgE receptors. J Allergy Clin Immunol 1999, 103:289-297.
46. Oliver B, Tomita K, Keller A, Caramori G, Adcock I, Chung KF, Barnes PJ, Lim S: Low-dose theophylline does not exert its anti-inflammatory effects in mild asthma through upregulation of interleukin-10 in alveolar macrophages. Allergy 2001, 56:1087-1090.
47. Maloy KJ, Powrie F: Regulatory T cells in the control of immune pathology. Nat Immunol 2001, 2:816-822.
48. Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, Sharpe AH, Berry G, DeKruyff RH, Umetsu DT: Antigen-specific regulatory T cells develop via the ICOS ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002, 8:1024-1032.
49. Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet LR, Kemeny DM, Bowen G, Rook G, Walker C: Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 2002, 8:625-629.